Revolution™ Peripheral Atherectomy System for Lower Extremity Peripheral Arterial Revascularization

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 121 participants.

Also called NCT02961894

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 121 participants (enrolled count) (from the registry)
Sponsor
  • Syntactx Registry lists this organization as a collaborator
Registry
  • NCT NCT02961894
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02961894. Allocation not applicable; no masking; primary purpose treatment. Start 2017-06-07 (actual); primary completion 2019-02-28 (actual). Results posted on 2020-11-02.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Revolution™ Peripheral Atherectomy System for Lower Extremity Peripheral Arterial Revascularization
Acronym
REVEAL
Condition
Peripheral Artery Disease
Intervention (Device)
Revolution™ Peripheral Atherectomy System
Lead sponsor
Rex Medical (class: industry)
Collaborator
Syntactx (class: research network)

Record details

Record id
cardio:ct-nct02961894
Content hash
7e96dac2f117af40a53ea85d65a73cfd673516f25a7ab540dfbbeab1e62ecc30